Total Funding
65
8
Total FundingSeries B raised
Growth Score
-16 pts
Heat Score
-15 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
483444
Sagent Pharmaceuticals is focused on developing, manufacturing, sourcing and marketing pharmaceutical products.
Acquired by 
Nichi-Iko Pharmaceutical
Jonathon Singer: CFO- Jeffrey Greve: EVP, Global Finance (CFO)Past Role: PricewaterhouseCoopers GmbH, Assurance Senior Manager
About the Company
Sagent Pharmaceuticals is a privately held specialty pharmaceutical company focused on developing, manufacturing, sourcing and marketing pharmaceutical products, with a specific emphasis on injectable products. Sagent has created a unique, global network of resources, comprised of rapid development capabilities, sophisticated manufacturing and
innovative drug-delivery technologies, quickly yielding an extensive portfolio of pharmaceutical products that fulfills the evolving needs of patients. Sagent currently has more than 200 products in development.
